Application 088322
- Type
- ANDA
- Sponsor
- PAR PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THIORIDAZINE HYDROCHLORIDE | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 50MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088322-001 | THIORIDAZINE HYDROCHLORIDE | THIORIDAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | 1983-12-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A088322-001 | THIORIDAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | 1983-12-05 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A088322-001 | THIORIDAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | 1983-12-05 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A088322-001 | THIORIDAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | 1983-12-05 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Safecor Health LLC | 1fd16a99-e856-4a37-9dae-c443714fac14 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | Thioridazine Hydrochloride THIORIDAZINE HYDROCHLORIDE |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Mylan Institutional Inc. | 52fea941-0b47-41c1-b00d-f88150e8ab93 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Thioridazine Hydrochloride THIORIDAZINE HYDROCHLORIDE |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Chartwell RX, LLC | e0bbe982-6434-468b-bd29-64ac57386fbe | 2025-02-19 | Boxed warning, Warnings, Adverse reactions | Thioridazine Hydrochloride THIORIDAZINE HYDROCHLORIDE |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 56b3f4c2-52af-4947-b225-6808ae9f26f5 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | Thioridazine Hydrochloride THIORIDAZINE HYDROCHLORIDE |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 9c4bedb4-2d59-4fcd-aad7-fce988cd96d8 | 2017-10-20 | Boxed warning, Warnings, Adverse reactions | Thioridazine Hydrochloride THIORIDAZINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.